₨ 18,000
Rebopag 25 mg tablets contain the active ingredient Eltrombopag, which is a prescription medication primarily used to treat low platelet counts (thrombocytopenia). It works by stimulating the bone marrow to produce more platelets, which helps reduce the risk of bleeding.
Key Information
- Active Ingredient: Eltrombopag (25 mg)
- Manufacturer: MSN Laboratories
- Uses: It is prescribed for several conditions involving low platelet counts:
- Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP): Used in adults and children (aged 1 year and above) when other treatments have been ineffective.
- Chronic Hepatitis C (HCV) Virus Infection: Used in adults to help initiate and optimize interferon-based therapy.
- Severe Aplastic Anemia (SAA): Used in adults and children (aged 2 years and above) in combination with other medications, or when other treatments have failed.
- Dosage & Administration: It is typically taken once daily on an empty stomach, at least one hour before or two hours after meals. It should be swallowed whole and not crushed or chewed.
- Common Side Effects: Common side effects can include nausea, diarrhea, headache, muscle pain, cough, tiredness, and fever.
- Serious Warnings: The medication can increase the risk of serious liver problems and blood clots. Regular blood tests are required to monitor liver function and platelet levels during treatment.
Always consult a healthcare professional for medical advice regarding this medication.
₨ 10,000
